Female pseudohermaphroditism with somatic chromosomal anomaly in association with in utero exposure to danazol
Case report
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This case report describes female pseudohermaphroditism in a patient with a somatic chromosomal anomaly, potentially linked to in utero exposure to danazol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (1)
Cited by (7)
- Danazol 2006
- Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis 1998
- The effects of fetal exposure to danazol 1992
- A new therapy for pelvic endometriosis and uterine adenomyosis: local effect of vaginal and intrauterine danazol application 1990
- Danazol and fetal masculinization: a warning 1985
- Danazol and urogenital sinus formation in pregnancy 1985
- Endometriosis 1984
Source provenance
- openalex
- last seen: 2026-05-10T11:09:15.517794+00:00
- pubmed
- last seen: 2026-10-08T21:58:32.052686+00:00
- unpaywall
- last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0
· commercial use OK